Clinically Valuable
- Detects and differentiates SARS-COV2, Influenza A, and Influenza B
- Point of Care results can be visually read in just 15 minutes
- Three clinical results from a single test
- Delta Variant Certified
Clinically Reliable
- COVID-19 - Sensitivity 93.8%, Specificity 100%
- Flu A - Sensitivity 91.4%, Specificity 95.7%
- Flu B - Sensitivity 87.6%, Specificity 95.9%
- Made in the U.S.A.
Easy to Use
- Pre-measured dose reagent (no counting drops)
- Streamlined testing procedure eliminates sample transfer
- Easy to read visual band signal for positives
- Flocked nasopharyngeal swab for patient comfort
Significant Reimbursement
- Bill 3 CPT codes from a single test
- COVID-19: 87811QW
- Flu A: 87804QW
- Flu B: 87804QW
CLIA Waived
Authorized under FDA Emergency Use Authorization (EUA) for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation in addition to moderate and high complexity laboratories.
Minimal Investment
Minimum order is only 25 tests.